Ortho-McNeil Pharmaceutical: Difference between revisions

Latest revision as of 16:32, 16 February 2025

Ortho-McNeil Pharmaceutical[edit]

The logo of Ortho-McNeil Pharmaceutical

Ortho-McNeil Pharmaceutical was a pharmaceutical company that operated as a subsidiary of Johnson & Johnson. It was known for developing and marketing a range of prescription medications, particularly in the fields of neurology, psychiatry, and women's health.

History[edit]

Ortho-McNeil Pharmaceutical was formed through the merger of two companies: Ortho Pharmaceutical and McNeil Pharmaceutical. Ortho Pharmaceutical was originally founded in 1931 and was known for its contributions to the field of contraception and women's health. McNeil Pharmaceutical, on the other hand, was established in 1879 and became well-known for its development of Tylenol, a widely used analgesic.

The merger of these two companies allowed Ortho-McNeil to leverage the strengths of both entities, expanding its product offerings and research capabilities. The company became a significant player in the pharmaceutical industry, particularly in the United States.

Products[edit]

Ortho-McNeil Pharmaceutical developed and marketed a variety of prescription medications. Some of the notable products included:

Topamax (topiramate) - An anticonvulsant used to treat epilepsy and prevent migraine headaches.
Levaquin (levofloxacin) - An antibiotic used to treat a variety of bacterial infections.
Ortho Tri-Cyclen - An oral contraceptive used for birth control and to treat acne.

Research and Development[edit]

The company invested heavily in research and development to bring new and innovative treatments to market. Ortho-McNeil's R&D efforts were focused on areas such as central nervous system disorders, infectious diseases, and women's health.

Merger and Transition[edit]

In 2008, Ortho-McNeil Pharmaceutical was merged with Janssen Pharmaceutica, another subsidiary of Johnson & Johnson, to form Ortho-McNeil-Janssen Pharmaceuticals. This merger was part of a strategic move to consolidate Johnson & Johnson's pharmaceutical operations and streamline its product offerings.

Related pages[edit]

@@ Line 1: / Line 1: @@
-Ortho-McNeil Pharmaceutical was a pharmaceutical company that was a subsidiary of Johnson & Johnson. The company was known for developing and manufacturing a wide range of pharmaceutical products, with a focus on medications for various medical conditions.
+== Ortho-McNeil Pharmaceutical ==
-== History ==
+[[File:Ortho_McNeil_logo.png|thumb|right|The logo of Ortho-McNeil Pharmaceutical]]
-Ortho-McNeil Pharmaceutical was founded in the early 20th century and quickly established itself as a leading pharmaceutical company. Over the years, the company developed a reputation for producing high-quality medications that were used to treat a variety of health issues.
-== Products ==
+'''Ortho-McNeil Pharmaceutical''' was a pharmaceutical company that operated as a subsidiary of [[Johnson & Johnson]]. It was known for developing and marketing a range of prescription medications, particularly in the fields of [[neurology]], [[psychiatry]], and [[women's health]].
-Ortho-McNeil Pharmaceutical produced a diverse range of pharmaceutical products, including medications for pain relief, cardiovascular health, and mental health. Some of the company's most well-known products included [[Tylenol]], a popular over-the-counter pain reliever, and [[Risperdal]], a medication used to treat schizophrenia and bipolar disorder.
-== Research and Development ==
+=== History ===
-Ortho-McNeil Pharmaceutical was committed to investing in research and development to create innovative new medications. The company worked closely with healthcare professionals and researchers to develop treatments that could improve the lives of patients suffering from various medical conditions.
+Ortho-McNeil Pharmaceutical was formed through the merger of two companies: Ortho Pharmaceutical and McNeil Pharmaceutical. Ortho Pharmaceutical was originally founded in 1931 and was known for its contributions to the field of [[contraception]] and women's health. McNeil Pharmaceutical, on the other hand, was established in 1879 and became well-known for its development of [[Tylenol]], a widely used [[analgesic]].
-== Acquisition by Johnson & Johnson ==
+The merger of these two companies allowed Ortho-McNeil to leverage the strengths of both entities, expanding its product offerings and research capabilities. The company became a significant player in the pharmaceutical industry, particularly in the United States.
-In 1993, Ortho-McNeil Pharmaceutical was acquired by Johnson & Johnson, a multinational healthcare company. Following the acquisition, Ortho-McNeil Pharmaceutical continued to operate as a subsidiary of Johnson & Johnson, leveraging the resources and expertise of its parent company to further its research and development efforts.
-== Legacy ==
+=== Products ===
-Although Ortho-McNeil Pharmaceutical is no longer an independent entity, its legacy lives on through the medications it developed and the impact it had on the pharmaceutical industry. Many of the products originally created by Ortho-McNeil Pharmaceutical are still in use today, helping patients around the world manage their health conditions.
+Ortho-McNeil Pharmaceutical developed and marketed a variety of prescription medications. Some of the notable products included:
+* '''Topamax''' (topiramate) - An [[anticonvulsant]] used to treat [[epilepsy]] and prevent [[migraine]] headaches.
+* '''Levaquin''' (levofloxacin) - An [[antibiotic]] used to treat a variety of bacterial infections.
+* '''Ortho Tri-Cyclen''' - An [[oral contraceptive]] used for birth control and to treat [[acne]].
+=== Research and Development ===
+The company invested heavily in [[research and development]] to bring new and innovative treatments to market. Ortho-McNeil's R&D efforts were focused on areas such as [[central nervous system]] disorders, [[infectious diseases]], and [[women's health]].
+=== Merger and Transition ===
+In 2008, Ortho-McNeil Pharmaceutical was merged with [[Janssen Pharmaceutica]], another subsidiary of Johnson & Johnson, to form [[Ortho-McNeil-Janssen Pharmaceuticals]]. This merger was part of a strategic move to consolidate Johnson & Johnson's pharmaceutical operations and streamline its product offerings.
+== Related pages ==
+* [[Johnson & Johnson]]
+* [[Janssen Pharmaceutica]]
+* [[Pharmaceutical industry]]
+* [[Oral contraceptive]]
+{{Johnson & Johnson}}
 [[Category:Pharmaceutical companies]]
 [[Category:Johnson & Johnson subsidiaries]]
-{{organization-stub}}